<p>梅特勒 - 托利多国际（NYSE:MTD - 获取免费报告）在周一发布的报告中，摩根大通将其目标股价从 1,413.00 美元下调至 1,200.00 美元。该公司目前对这家医疗仪器供应商的股票给予 “中性” 评级。摩根大通的目标价暗示该股票当前价格有 10.64% 的上涨潜力。</p>
<ul>
<li>Matador 的业绩好于预期，但 2026 年的挑战仍然存在</li>
</ul>
<p>其他几家股票研究分析师也对该股票发布了报告。花旗集团将梅特勒 - 托利多国际的目标股价从 1,700.00 美元下调至 1,550.00 美元，并在周五的报告中给予该公司 “买入” 评级。摩根士丹利将梅特勒 - 托利多国际的目标股价从 1,550.00 美元下调至 1,475.00 美元，并在 2 月 10 日的报告中给予该公司 “持平” 评级。杰富瑞金融集团在 3 月 20 日的报告中将梅特勒 - 托利多国际的评级从 “持有” 上调至 “买入”，并将其目标价从 1,400.00 美元上调至 1,450.00 美元。罗伯特·W·贝尔德将梅特勒 - 托利多国际的目标价从 1,445.00 美元下调至 1,194.00 美元，并在周一的报告中给予该公司 “中性” 评级。最后，华尔街 Zen 在 2 月 14 日的报告中将梅特勒 - 托利多国际的评级从 “持有” 上调至 “买入”。七位研究分析师对该股票给予 “买入” 评级，六位分析师给予 “持有” 评级。根据 MarketBeat.com 的数据，梅特勒 - 托利多国际目前的平均评级为 “适度买入”，共识目标价为 1,437.00 美元。</p>
<p><strong>查看我们关于梅特勒 - 托利多国际的最新报告</strong></p>
<h2>梅特勒 - 托利多国际股票表现</h2>
<ul>
<li>3 家中型能源公司分析师认为将晋升至大联盟</li>
</ul>
<p>周一，NYSE:MTD 的股票下跌 39.84 美元，达到 1,084.62 美元。该公司的股票交易量为 163,567 股，而其平均交易量为 154,988 股。该公司的 50 日简单移动平均线为 1,276.49 美元，200 日简单移动平均线为 1,367.66 美元。该公司的市值为 219.6 亿美元，市盈率为 25.46，PEG 比率为 2.36，贝塔值为 1.31。梅特勒 - 托利多国际的 52 周低点为 1,087.12 美元，52 周高点为 1,525.17 美元。</p>
<p>梅特勒 - 托利多国际（NYSE:MTD - 获取免费报告）最后一次发布财报是在 5 月 7 日，医疗仪器供应商报告该季度每股收益（EPS）为 8.91 美元，超出市场共识预期的 8.70 美元，超出 0.21 美元。该季度的收入为 9.4713 亿美元，而分析师预期为 9.4314 亿美元。梅特勒 - 托利多国际的净利润率为 21.40%，股本回报率为-622.80%。该公司的收入同比增长 7.2%。去年同期，该公司每股收益为 8.19 美元。梅特勒 - 托利多国际已将其 2026 财年的指导目标设定为 46.300-46.950 EPS，2026 年第二季度的指导目标为 10.700-10.850 EPS。平均而言，股票研究分析师预测梅特勒 - 托利多国际在当前财年将发布 46.54 EPS。</p>
<h2>内部人士下注</h2>
<ul>
<li>根据分析师的说法，5 只高评级股息的上涨潜力达到 50%</li>
</ul>
<p>在其他梅特勒 - 托利多国际的新闻中，首席财务官肖恩·瓦达拉在 2 月 10 日的交易中出售了 800 股该公司的股票。股票以平均价格 1,410.12 美元出售，总交易额为 1,128,096.00 美元。交易后，首席财务官持有 5,288 股公司股票，价值约为 7,456,714.56 美元。这笔交易代表其持股减少了 13.14%。该交易已在向 SEC 提交的文件中披露，文件可在此链接查看。内部人士持有该股票的 0.71%。</p>
<h2>机构资金流入和流出</h2>
<p>一些机构投资者最近增加或减少了在该公司的持股。EverSource Wealth Advisors LLC 在第三季度将其在梅特勒 - 托利多国际的持股增加了 2.4%。EverSource Wealth Advisors LLC 目前持有 294 股医疗仪器供应商的股票，价值 361,000 美元，此前在该期间内购买了额外的 7 股。Allworth Financial LP 在第三季度将其在梅特勒 - 托利多国际的持股增加了 6.1%。Allworth Financial LP 目前持有 121 股医疗仪器供应商的股票，价值 149,000 美元，此前在该期间内购买了额外的 7 股。Versant Capital Management Inc 在第三季度将其在梅特勒 - 托利多国际的持股增加了 42.1%。Versant Capital Management Inc 目前持有 27 股医疗仪器供应商的股票，价值 33,000 美元，此前在该期间内购买了额外的 8 股。Valeo Financial Advisors LLC 在第三季度将其在梅特勒 - 托利多国际的持股增加了 4.0%。Valeo Financial Advisors LLC 目前持有 207 股医疗仪器供应商的股票，价值 254,000 美元，此前在该期间内购买了额外的 8 股。最后，Meridian Wealth Management LLC 在第三季度将其在梅特勒 - 托利多国际的持股增加了 1.7%。Meridian Wealth Management LLC 目前持有 480 股医疗仪器供应商的股票，价值 589,000 美元，此前在该期间内购买了额外的 8 股。对冲基金和其他机构投资者持有该公司 95.07% 的股票。</p>
<h2>关于梅特勒 - 托利多国际</h2>
<p>（获取免费报告）</p>
<p>梅特勒 - 托利多国际公司是一家全球制造和分销实验室、工业和食品零售应用精密仪器及服务的公司。公司的产品组合包括实验室天平和分析仪器、工业称重系统、过程分析和传感器、金属探测和 X 射线检查设备、检重秤，以及一系列自动化检查和数据管理解决方案。梅特勒 - 托利多还提供软件、校准和生命周期服务，旨在支持客户设施的合规性、质量控制和运营效率。</p>
<p>该公司服务于广泛的终端市场，包括制药和生物技术实验室、化工和食品加工、物流和制造操作，以及对准确称重和检查至关重要的零售环境。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过梅特勒 - 托利多国际</li>
<li>在月球基地建成之前，这四家公司获胜</li>
<li>工业回购：顶级住宅建筑供应商引领回购增加</li>
<li>如果通胀意外下行，这三只股票将获利</li>
<li>MercadoLibre 大胆投资于增长：折扣加深</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1URA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1URA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在梅特勒 - 托利多国际吗？</h2>
<p>在考虑梅特勒 - 托利多国际之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而梅特勒 - 托利多国际并不在名单上。</p>
<p>虽然梅特勒 - 托利多国际目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

梅特勒-托利多

摩根大通

<p>摩根大通已将梅特勒 - 托利多国际（NYSE:MTD）的目标股价从 1,413.00 美元下调至 1,200.00 美元，维持 “中性” 评级。这表明与当前股价相比，潜在上涨幅度为 10.64%。其他分析师也调整了他们的评级，花旗集团设定的目标为 1,550.00 美元，摩根士丹利为 1,475.00 美元。梅特勒 - 托利多的股票最近交易价格为 1,084.62 美元，市值为 219.6 亿美元，市盈率为 25.46。该公司报告每股收益为 8.91 美元，超出预期</p>

<p>Mettler-Toledo International (NYSE:MTD - Get Free Report) had its price target decreased by analysts at JPMorgan Chase &amp; Co. from $1,413.00 to $1,200.00 in a report issued on Monday,Benzinga reports. The firm currently has a &#34;neutral&#34; rating on the medical instruments supplier's stock. JPMorgan Chase &amp; Co.'s price objective suggests a potential upside of 10.64% from the stock's current price.</p>
<div class="lb-trans"><p>梅特勒 - 托利多国际（NYSE:MTD - 获取免费报告）在周一发布的报告中，摩根大通将其目标股价从 1,413.00 美元下调至 1,200.00 美元。该公司目前对这家医疗仪器供应商的股票给予 “中性” 评级。摩根大通的目标价暗示该股票当前价格有 10.64% 的上涨潜力。</p>
</div><ul>
<li>Matador’s Results Were Better Than Feared, But 2026 Headwinds Still Matter</li>
</ul>
<div class="lb-trans"><ul>
<li>Matador 的业绩好于预期，但 2026 年的挑战仍然存在</li>
</ul>
</div><p>Several other equities research analysts have also issued reports on the stock. Citigroup lowered their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a &#34;buy&#34; rating for the company in a report on Friday. Morgan Stanley lowered their target price on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an &#34;equal weight&#34; rating for the company in a report on Tuesday, February 10th. Jefferies Financial Group upgraded shares of Mettler-Toledo International from a &#34;hold&#34; rating to a &#34;buy&#34; rating and lifted their price objective for the company from $1,400.00 to $1,450.00 in a report on Friday, March 20th. Robert W. Baird decreased their price objective on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a &#34;neutral&#34; rating for the company in a report on Monday. Finally, Wall Street Zen upgraded shares of Mettler-Toledo International from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, February 14th. Seven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, Mettler-Toledo International presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $1,437.00.</p>
<div class="lb-trans"><p>其他几家股票研究分析师也对该股票发布了报告。花旗集团将梅特勒 - 托利多国际的目标股价从 1,700.00 美元下调至 1,550.00 美元，并在周五的报告中给予该公司 “买入” 评级。摩根士丹利将梅特勒 - 托利多国际的目标股价从 1,550.00 美元下调至 1,475.00 美元，并在 2 月 10 日的报告中给予该公司 “持平” 评级。杰富瑞金融集团在 3 月 20 日的报告中将梅特勒 - 托利多国际的评级从 “持有” 上调至 “买入”，并将其目标价从 1,400.00 美元上调至 1,450.00 美元。罗伯特·W·贝尔德将梅特勒 - 托利多国际的目标价从 1,445.00 美元下调至 1,194.00 美元，并在周一的报告中给予该公司 “中性” 评级。最后，华尔街 Zen 在 2 月 14 日的报告中将梅特勒 - 托利多国际的评级从 “持有” 上调至 “买入”。七位研究分析师对该股票给予 “买入” 评级，六位分析师给予 “持有” 评级。根据 MarketBeat.com 的数据，梅特勒 - 托利多国际目前的平均评级为 “适度买入”，共识目标价为 1,437.00 美元。</p>
</div><p><strong>View Our Latest Report on Mettler-Toledo International</strong></p>
<div class="lb-trans"><p><strong>查看我们关于梅特勒 - 托利多国际的最新报告</strong></p>
</div><h2>Mettler-Toledo International Stock Performance</h2>
<div class="lb-trans"><h2>梅特勒 - 托利多国际股票表现</h2>
</div><ul>
<li>3 Mid-Cap Energy Firms Analysts See Moving Up to the Big Leagues</li>
</ul>
<div class="lb-trans"><ul>
<li>3 家中型能源公司分析师认为将晋升至大联盟</li>
</ul>
</div><p>Shares of NYSE:MTD traded down $39.84 on Monday, reaching $1,084.62. The company's stock had a trading volume of 163,567 shares, compared to its average volume of 154,988. The company has a 50-day simple moving average of $1,276.49 and a 200 day simple moving average of $1,367.66. The company has a market cap of $21.96 billion, a P/E ratio of 25.46, a PEG ratio of 2.36 and a beta of 1.31. Mettler-Toledo International has a 52-week low of $1,087.12 and a 52-week high of $1,525.17.</p>
<div class="lb-trans"><p>周一，NYSE:MTD 的股票下跌 39.84 美元，达到 1,084.62 美元。该公司的股票交易量为 163,567 股，而其平均交易量为 154,988 股。该公司的 50 日简单移动平均线为 1,276.49 美元，200 日简单移动平均线为 1,367.66 美元。该公司的市值为 219.6 亿美元，市盈率为 25.46，PEG 比率为 2.36，贝塔值为 1.31。梅特勒 - 托利多国际的 52 周低点为 1,087.12 美元，52 周高点为 1,525.17 美元。</p>
</div><p>Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $8.70 by $0.21. The firm had revenue of $947.13 million during the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a net margin of 21.40% and a negative return on equity of 622.80%. The business's revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the business earned $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. On average, equities research analysts forecast that Mettler-Toledo International will post 46.54 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>梅特勒 - 托利多国际（NYSE:MTD - 获取免费报告）最后一次发布财报是在 5 月 7 日，医疗仪器供应商报告该季度每股收益（EPS）为 8.91 美元，超出市场共识预期的 8.70 美元，超出 0.21 美元。该季度的收入为 9.4713 亿美元，而分析师预期为 9.4314 亿美元。梅特勒 - 托利多国际的净利润率为 21.40%，股本回报率为-622.80%。该公司的收入同比增长 7.2%。去年同期，该公司每股收益为 8.19 美元。梅特勒 - 托利多国际已将其 2026 财年的指导目标设定为 46.300-46.950 EPS，2026 年第二季度的指导目标为 10.700-10.850 EPS。平均而言，股票研究分析师预测梅特勒 - 托利多国际在当前财年将发布 46.54 EPS。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><ul>
<li>5 Highly Rated Dividends With 50% Upside According to Analysts</li>
</ul>
<div class="lb-trans"><ul>
<li>根据分析师的说法，5 只高评级股息的上涨潜力达到 50%</li>
</ul>
</div><p>In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the firm's stock in a transaction dated Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the transaction, the chief financial officer owned 5,288 shares of the company's stock, valued at approximately $7,456,714.56. This trade represents a 13.14% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.71% of the stock is owned by insiders.</p>
<div class="lb-trans"><p>在其他梅特勒 - 托利多国际的新闻中，首席财务官肖恩·瓦达拉在 2 月 10 日的交易中出售了 800 股该公司的股票。股票以平均价格 1,410.12 美元出售，总交易额为 1,128,096.00 美元。交易后，首席财务官持有 5,288 股公司股票，价值约为 7,456,714.56 美元。这笔交易代表其持股减少了 13.14%。该交易已在向 SEC 提交的文件中披露，文件可在此链接查看。内部人士持有该股票的 0.71%。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of institutional investors have recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC increased its position in Mettler-Toledo International by 2.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 294 shares of the medical instruments supplier's stock valued at $361,000 after purchasing an additional 7 shares during the period. Allworth Financial LP increased its position in Mettler-Toledo International by 6.1% during the 3rd quarter. Allworth Financial LP now owns 121 shares of the medical instruments supplier's stock valued at $149,000 after purchasing an additional 7 shares during the period. Versant Capital Management Inc increased its position in Mettler-Toledo International by 42.1% during the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier's stock valued at $33,000 after purchasing an additional 8 shares during the period. Valeo Financial Advisors LLC increased its position in Mettler-Toledo International by 4.0% during the 3rd quarter. Valeo Financial Advisors LLC now owns 207 shares of the medical instruments supplier's stock valued at $254,000 after purchasing an additional 8 shares during the period. Finally, Meridian Wealth Management LLC increased its position in Mettler-Toledo International by 1.7% during the 3rd quarter. Meridian Wealth Management LLC now owns 480 shares of the medical instruments supplier's stock valued at $589,000 after purchasing an additional 8 shares during the period. Hedge funds and other institutional investors own 95.07% of the company's stock.</p>
<div class="lb-trans"><p>一些机构投资者最近增加或减少了在该公司的持股。EverSource Wealth Advisors LLC 在第三季度将其在梅特勒 - 托利多国际的持股增加了 2.4%。EverSource Wealth Advisors LLC 目前持有 294 股医疗仪器供应商的股票，价值 361,000 美元，此前在该期间内购买了额外的 7 股。Allworth Financial LP 在第三季度将其在梅特勒 - 托利多国际的持股增加了 6.1%。Allworth Financial LP 目前持有 121 股医疗仪器供应商的股票，价值 149,000 美元，此前在该期间内购买了额外的 7 股。Versant Capital Management Inc 在第三季度将其在梅特勒 - 托利多国际的持股增加了 42.1%。Versant Capital Management Inc 目前持有 27 股医疗仪器供应商的股票，价值 33,000 美元，此前在该期间内购买了额外的 8 股。Valeo Financial Advisors LLC 在第三季度将其在梅特勒 - 托利多国际的持股增加了 4.0%。Valeo Financial Advisors LLC 目前持有 207 股医疗仪器供应商的股票，价值 254,000 美元，此前在该期间内购买了额外的 8 股。最后，Meridian Wealth Management LLC 在第三季度将其在梅特勒 - 托利多国际的持股增加了 1.7%。Meridian Wealth Management LLC 目前持有 480 股医疗仪器供应商的股票，价值 589,000 美元，此前在该期间内购买了额外的 8 股。对冲基金和其他机构投资者持有该公司 95.07% 的股票。</p>
</div><h2>About Mettler-Toledo International</h2>
<div class="lb-trans"><h2>关于梅特勒 - 托利多国际</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company's product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.</p>
<div class="lb-trans"><p>梅特勒 - 托利多国际公司是一家全球制造和分销实验室、工业和食品零售应用精密仪器及服务的公司。公司的产品组合包括实验室天平和分析仪器、工业称重系统、过程分析和传感器、金属探测和 X 射线检查设备、检重秤，以及一系列自动化检查和数据管理解决方案。梅特勒 - 托利多还提供软件、校准和生命周期服务，旨在支持客户设施的合规性、质量控制和运营效率。</p>
</div><p>The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.</p>
<div class="lb-trans"><p>该公司服务于广泛的终端市场，包括制药和生物技术实验室、化工和食品加工、物流和制造操作，以及对准确称重和检查至关重要的零售环境。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Mettler-Toledo International</li>
<li>Before the Moon Base Gets Built, These 4 Companies Win</li>
<li>Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases</li>
<li>3 Stocks That Win If Inflation Surprises to the Downside</li>
<li>MercadoLibre Boldly Invests in Growth: Discount Deepens</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过梅特勒 - 托利多国际</li>
<li>在月球基地建成之前，这四家公司获胜</li>
<li>工业回购：顶级住宅建筑供应商引领回购增加</li>
<li>如果通胀意外下行，这三只股票将获利</li>
<li>MercadoLibre 大胆投资于增长：折扣加深</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1URA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NYSE&amp;Symbol=MTD"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Mettler-Toledo International Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在梅特勒 - 托利多国际吗？</h2>
</div><p>Before you consider Mettler-Toledo International, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑梅特勒 - 托利多国际之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而梅特勒 - 托利多国际并不在名单上。</p>
</div><p>While Mettler-Toledo International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然梅特勒 - 托利多国际目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

JPMorgan Chase & Co. Issues Pessimistic Forecast for Mettler-Toledo International (NYSE:MTD) Stock Price

Market Beat

花旗

摩根士丹利

Jefferies Financial

Matador资源

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

CITIGROUP INC 6.250 NON CUM SER II PFD WI

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

摩根大通对梅特勒 - 托利多国际公司（NYSE: MTD）的股价发布了悲观的预测